Related Experiment Video
Updated: May 12, 2026
12:48
PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
Published on: December 27, 2013
Nanostructured poly(L-lactide) matrix as novel platform for drug delivery
Jianzhi Zhou1, Songling Han, Yin Dou
1Department of Pharmaceutics, College of Pharmacy, Third Military Medical University, Chongqing 400038, China.
International Journal of Pharmaceutics
|March 29, 2013
Summary
Researchers developed a new method to create drug-loaded poly(l-lactide) nanostructures for drug delivery and tissue engineering. This technique allows for controlled drug release and the creation of bioactive scaffolds.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Polymer Chemistry
Background:
- Developing advanced materials for controlled drug delivery and tissue regeneration is crucial.
- Poly(l-lactide) (PLLA) offers biocompatibility and biodegradability for biomedical applications.
Purpose of the Study:
- To establish novel strategies for fabricating bioactive nanostructured matrices using PLLA.
- To enable controlled drug delivery and potential tissue engineering applications.
Main Methods:
- A facile, one-pot protocol utilizing thermally induced phase separation was employed.
- Lipophilic drugs were incorporated into nanosheet-like or nanofibrous PLLA matrices.
- Hydrophilic compounds were loaded via post-fabrication absorption into nanofibrous structures.
Main Results:
- Efficient incorporation of lipophilic drugs (steroidal and nonsteroidal anti-inflammatory) into PLLA nanostructures was achieved.
- Drug release kinetics were modulated by nanostructure morphology and polymer concentration.
- The method allows for the creation of drug-loaded nanostructures with randomly distributed, nanoscaled drug crystals.
Conclusions:
- The developed method provides a versatile approach for producing drug-loaded PLLA nanostructures.
- These nanostructures show potential for controlled drug delivery, with tunable release profiles.
- The strategy facilitates the construction of bioactive scaffolds for tissue regeneration and biotherapy.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...